You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Johnson and Johnson
Mallinckrodt
McKinsey
Merck

Last Updated: February 27, 2021

DrugPatentWatch Database Preview

Indomethacin - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for indomethacin and what is the scope of freedom to operate?

Indomethacin is the generic ingredient in six branded drugs marketed by Egalet, Able, Amneal Pharms, Aurobindo Pharma Ltd, Avanthi Inc, Chartwell Rx, Glenmark Pharms Ltd, Hetero Labs Ltd Iii, Inwood Labs, Jubilant Generics, Mylan, Novast Labs, Sandoz, Watson Labs Inc, Zydus Pharms, Teva, Ani Pharms Inc, Cadila, Chartwell Molecules, Cycle Pharms Ltd, Duramed Pharms Barr, Glenmark Generics, Halsey, Heritage, Heritage Pharma, Ivax Sub Teva Pharms, Mutual Pharm, Parke Davis, Pioneer Pharms, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, Watson Labs, Genus, Fresenius Kabi Usa, Cosette, Hikma, Recordati Rare, Hospira Inc, Navinta Llc, and West-ward Pharms Int, and is included in seventy NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Indomethacin has thirty-seven patent family members in twenty-one countries.

There are fifteen drug master file entries for indomethacin. Thirty suppliers are listed for this compound.

Drug Prices for indomethacin

See drug prices for indomethacin

Drug Sales Revenue Trends for indomethacin

See drug sales revenues for indomethacin

Recent Clinical Trials for indomethacin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Laval UniversityPhase 3
CHU de Quebec-Universite LavalPhase 3
Woman'sN/A

See all indomethacin clinical trials

Pharmacology for indomethacin
Paragraph IV (Patent) Challenges for INDOMETHACIN
Tradename Dosage Ingredient NDA Submissiondate
INDOCIN SR CAPSULE, EXTENDED RELEASE;ORAL indomethacin 018185

US Patents and Regulatory Information for indomethacin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Egalet INDOCIN indomethacin SUSPENSION;ORAL 018332-001 Oct 10, 1985 RX Yes Yes   Start Trial   Start Trial   Start Trial
Hetero Labs Ltd Iii INDOMETHACIN indomethacin CAPSULE;ORAL 091240-001 Apr 12, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan INDOMETHACIN indomethacin CAPSULE;ORAL 018858-001 Apr 20, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Superpharm INDOMETHACIN indomethacin CAPSULE;ORAL 070488-001 Oct 10, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs INDOMETHACIN indomethacin CAPSULE;ORAL 070785-001 Aug 20, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Teva INDO-LEMMON indomethacin CAPSULE;ORAL 070266-001 Nov 7, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for indomethacin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Egalet INDOCIN SR indomethacin CAPSULE, EXTENDED RELEASE;ORAL 018185-001 Feb 23, 1982   Start Trial   Start Trial
Egalet INDOCIN indomethacin SUPPOSITORY;RECTAL 017814-001 Aug 13, 1984   Start Trial   Start Trial
Egalet INDOCIN indomethacin SUPPOSITORY;RECTAL 017814-001 Aug 13, 1984   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
McKinsey
Harvard Business School
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.